AurorA debuts to back early-stage European biotechs

A new Europe-focused investment vehicle has launched with €10 million in backing from two Italian biopharmas.

AurorA Science will be managed by

Read the full 213 word article

How to gain access

Continue reading with a
two-week free trial.